Associação entre osteoporose e artrite reumatóide em mulheres
Estudo transversal
Palavras-chave:
Artrite reumatóide, Osteoporose, Dieta, Composição corporal, Atividade física. Hormônio paratireóideoResumo
CONTEXTO E OBJETIVO: A osteoporose é frequentemente observada em pacientes com artrite reumatoide (AR). O presente estudo foi realizado com o objetivo de avaliar fatores associados a osteoporose em mulheres com AR. TIPO DE ESTUDO E LOCAL: Estudo transversal realizado em um hospital público em São Paulo. MÉTODOS: Participaram 83 mulheres com AR (53.7 ± 10.0 anos). A densidade mineral óssea (DMO) e composição corporal foram mensuradas pelo método de densitômetro de dupla emissão com fonte de raios-X. Houve a divisão em grupos conforme a DMO: grupo 1 DMO normal (n = 24); grupo 2 osteopenia (n = 38) e grupo 3 osteoporose (n = 21). Foram realizados testes para comparar diferenças de médias e correlações ajustadas para idade, duração da doença e corticosteroide acumulado. A relação entre fatores clínicos, escore de atividade física, consumo alimentar, composição corporal e parâmetros bioquímicos foram analisados pelo modelo de regressão linear. RESULTADOS: A média de consumo de cálcio, vitamina D e ômega-6 esteve abaixo do recomendado. Houve associação entre DMO e idade, duração da doença, hormônio da paratireóide (PTH) e consumo de gordura. O modelo de regressão linear evidenciou que ser mais velho, apresentar mais anos de doença e menor peso correlacionam-se negativamente com a DMO. [Fêmur total = 0.552 + 0.06 (peso) + 0.019 (atividade física total) – 0.05 (idade) – 0.003 (duração da doença), R2 = 48.1; P < 0.001]. CONCLUSÃO: O presente estudo indica que fatores nutricionais e de composição corporal estão associados com a massa óssea em mulheres com AR.
Downloads
Referências
Brandão L, Ferraz MB, Zerbini CAF. Avaliação da qualidade de vida na artrite reumatóide: revisão atualizada [Evaluation of quality of life in rheumatoid arthritis]. Rev Bras Reumatol. 1997;37(5):275-81.
Pattison DJ, Harrison RA, Symmons DP. The role of diet in susceptibility to rheumatoid arthri- tis: a systematic review. J Rheumatol. 2004;31(7):1310-9.
Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 2001;27(2):269-81.
Martin JC, Munro R, Campbell MK, Reid DM. Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol. 1999;36(1):43-9.
Lodder MC, Haugeberg G, Lems WF, et al. Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study. Arthritis Rheum. 2003;49(2):209-15.
Bezerra MC, Carvalho JF, Prokopowitsch AS, Pereira RM. RANK, RANKL and osteoprotegerin in arthritic bone loss. Braz J Med Biol Res. 2005;38(2):161-70.
van Staa TP. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int. 2006;79(3):129-37.
Stone J, Doube A, Dudson D, Wallace J. Inadequate calcium, folic acid, vitamin E, zinc, and selenium intake in rheumatoid arthritis patients: results of a dietary survey. Semin Arthritis Rheum. 1997;27(3):180-5.
Roubenoff R, Roubenoff RA, Cannon JG, et al. Rheumatoid cachexia: cytokine-driven hyper- metabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest. 1994;93(6):2379-86.
Beck TJ, Oreskovic TL, Stone KL, et al. Structural adaptation to changing skeletal load in progression toward hip fragility: the study of osteoporotic fractures. J Bone Miner Res. 2001;16(6):1108-19.
Reid IR, Plank LD, Evans MC. Fat mass is an important determinant of whole body bone den- sity in premenopausal women but not in men. J Clin Endocrinol Metab. 1992;75(3):779-82.
Lina JB, Stein GS, Canalis E, Robey PG, Boskey AL. Bone formation: osteoblast lineage cells, growth factors, matrix proteins, and the mineralization process. In: Favus MJ, editor. Primer on the metabolic bone disease and disorders of mineral metabolism. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 1999. p. 14-29.
Heaney RP. Protein and calcium: antagonists or synergists? Am J Clin Nutr. 2002;75(4): 609-10.
Basu S, Michaëlsson K, Olofsson H, Johansson S, Melhus H. Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun. 2001;288(1):275-9.
Mody N, Parhami F, Sarafian TA, Demer LL. Oxidative stress modulates osteoblastic differen- tiation of vascular and bone cells. Free Radic Biol Med. 2001;31(4):509-19.
Martínez-Ramírez MJ, Palma S, Martínez-González MA, Delgado-Martínez AD, de la Fuente C, Delgado-Rodríguez M. Dietary fat intake and the risk of osteoporotic fractures in the elderly. Eur J Clin Nutr. 2007;61(9):1114-20.
Kruger MC, Horrobin DF. Calcium metabolism, osteoporosis and essential fatty acids: a review. Prog Lipid Res. 1997;36(2-3):131-51.
Claassen N, Coetzer H, Steinmann CM, Kruger MC. The effect of different n-6/n-3 essential fatty acid rations on calcium balance and bone in rats. Prostaglandins Leukot Essent Fatty Acids. 1995;53(1):13-9.
Das UN. Essential fatty acids and osteoporosis. Nutrition. 2000;16(5):386-90.
Priante G, Bordin L, Musacchio E, Clari G, Baggio B. Fatty acids and cytokine mRNA ex- pression in human osteoblastic cells: a specific effect of arachidonic acid. Clin Sci (Lond). 2002;102(4):403-9.
Meydani SN, Endres S, Woods MM, et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr. 1991;121(4):547-55.
Weiss LA, Barrett-Connor E, von Mühlen D. Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr. 2005;81(4):934-8.
Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Bio- med Pharmacother. 2002;56(8):365-79.
Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood). 2008;233(6):674-88.
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315-24.
Assessment of fracture risk and its application to screening for postmenopausal osteoporo- sis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994;843:1-129.
Levin J. Estatística aplicada a ciências humanas. 2a ed. São Paulo: Harbra Ltda; 1987.
Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthri- tis Rheum. 1980;23(2):137-45.
Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44-8.
Pereira GA, Genaro PS, Santos LC, et al. Validation of a food frequency questionnaire for women with osteoporosis. J Nutr Health Aging. 2009;13(5):403-7.
Willett W, Stampfer M. Implications of total energy intake for epidemiological analyses. In: Willett W, editor. Nutrition epidemiology 2nd ed. New York: Oxford University Press; 1998. p. 273-301.
Food and Nutrition Board. Institute of Medicine. Dietary reference intakes for energy, car- bohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). Washington: National Academy Press; 2005. Available from: http://www.nap.edu/catalog. php?record_id=10490#orgs. Accessed in 2009 (Aug 10).
Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vi- tamin D and fluoride. Washington: National Academy Press; 1997. Available from: http:// www.nap.edu/catalog.php?record_id=5776. Accessed in 2009 (Aug 10).
Baeck JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36(5):936-42.
Baumgartner RN, Stauber PM, Koehler KM, Romero L, Garry PJ. Associations of fat and muscle masses with bone mineral in elderly men and women. Am J Clin Nutr. 1996;63(3):365-72.
Munro R, Capell H. Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response. Ann Rheum Dis. 1997;56(5):326-9.
Summers GD, Deighton CM, Rennie MJ, Booth AH. Rheumatoid cachexia: a clinical perspec- tive. Rheumatology (Oxford). 2008;47(8):1124-31.
Lanyon L, Skerry T. Postmenopausal osteoporosis as a failure of bone’s adaptation to func- tional loading: a hypothesis. J Bone Miner Res. 2001;16(11):1937-47.
Chung CP, Russell AS, Segami MI, Ugarte CA. The effect of low-dose prednisone on bone mi- neral density in Peruvian rheumatoid arthritis patients. Rheumatol Int. 2005;25(2):114-7.
Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum. 1985;28(4):361-8.
Saraiva GL, Cendoroglo MS, Ramos LR, et al. Prevalência da deficiência, insuficiência de vitamina D e hiperparatiroidismo secundário em idosos institucionalizados e moradores na comunidade da cidade de São Paulo, Brasil [Prevalence of vitamin D deficiency, insuffi- ciency and secondary hyperparathyroidism in the elderly inpatients and living in the com- munity of the city of São Paulo, Brazil]. Arq Bras Endocrinol Metabol. 2007;51(3):437-42.
Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991;54(3):438-63.
Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr. 1999;70(3 Suppl):560S-569S.
Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83(6 Suppl):1505S-1519S.
Sambrook PN, Spector TD, Seeman E, et al. Osteoporosis in rheumatic arthritis. A monozygo- tic co-twin control study. Arthritis Rheum. 1995;38(6):806-9.
Oelzner P, Müller A, Deschner F, et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int. 1998;62(3):193-8.
Saag KG, Shane E, Boonen S, et al. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med. 2007;357(20):2028-39.
Masi L, Simonini G, Piscitelli E, et al. Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury? J Rheumatol. 2004;31(5):986-91.
Romas E, Gillespie MT. Inflammation-induced bone loss: can it be prevented? Rheum Dis Clin North Am. 2006,32(4):759-73.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
